UCT-03-008

N/A

Report date: 2024/12/18 13:39:48
NME

Base Information

Drug NameUCT-03-008
Drug Alias NameUCT-03-008
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionProtein kinases inhibitors
TargetsProtein kinases
Therapy Area/IndicationsSolid tumours
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator Companies1200 Pharma LLC
China Registration ClassN/A

Develop Information

Active Companies1200 Pharma LLC
Inactive CompaniesN/A
Active IndicationsSolid tumours
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A